Das Saurav, Shu Liqi, Morgan Rebecca J, Shah Asghar, Fayad Fayez H, Goldstein Eric D, Chahien Dalia, Maglinger Benton, Bokka Satish Kumar, Owens Cory, Abbasi Mehdi, Kvernland Alexandra, Siegler James E, Grory Brian Mac, Nguyen Thanh N, Furie Karen, Khatri Pooja, Mistry Eva, Prabhakaran Shyam, Liebeskind David S, Romano Jose G, Havenon Adam de, Palaiodimou Lina, Tsivgoulis Georgios, Yaghi Shadi
Department of Neurology, University of Kentucky, Louisville, KY, USA.
Department of Neurology, Brown University, Providence, RI, USA.
J Stroke. 2023 May;25(2):223-232. doi: 10.5853/jos.2023.00185. Epub 2023 May 30.
Intracranial arterial stenosis (ICAS)-related stroke occurs due to three primary mechanisms with distinct infarct patterns: (1) borderzone infarcts (BZI) due to impaired distal perfusion, (2) territorial infarcts due to distal plaque/thrombus embolization, and (3) plaque progression occluding perforators. The objective of the systematic review is to determine whether BZI secondary to ICAS is associated with a higher risk of recurrent stroke or neurological deterioration.
As part of this registered systematic review (CRD42021265230), a comprehensive search was performed to identify relevant papers and conference abstracts (with ≥20 patients) reporting initial infarct patterns and recurrence rates in patients with symptomatic ICAS. Subgroup analyses were performed for studies including any BZI versus isolated BZI and those excluding posterior circulation stroke. The study outcome included neurological deterioration or recurrent stroke during follow-up. For all outcome events, corresponding risk ratios (RRs) and 95% confidence intervals (95% CI) were calculated.
A literature search yielded 4,478 records with 32 selected during the title/abstract triage for full text; 11 met inclusion criteria and 8 studies were included in the analysis (n=1,219 patients; 341 with BZI). The meta-analysis demonstrated that the RR of outcome in the BZI group compared to the no BZI group was 2.10 (95% CI 1.52-2.90). Limiting the analysis to studies including any BZI, the RR was 2.10 (95% CI 1.38-3.18). For isolated BZI, RR was 2.59 (95% CI 1.24-5.41). RR was 2.96 (95% CI 1.71-5.12) for studies only including anterior circulation stroke patients.
This systematic review and meta-analysis suggests that the presence of BZI secondary to ICAS may be an imaging biomarker that predicts neurological deterioration and/or stroke recurrence.
颅内动脉狭窄(ICAS)相关的卒中是由三种主要机制导致的,这些机制具有不同的梗死模式:(1)由于远端灌注受损导致的边缘带梗死(BZI);(2)由于远端斑块/血栓栓塞导致的区域梗死;(3)斑块进展阻塞穿支动脉。本系统评价的目的是确定ICAS继发的BZI是否与复发性卒中或神经功能恶化的风险更高相关。
作为这项注册系统评价(CRD42021265230)的一部分,进行了全面检索,以识别报告有症状ICAS患者的初始梗死模式和复发率的相关论文和会议摘要(患者≥20例)。对包括任何BZI与孤立BZI的研究以及排除后循环卒中的研究进行亚组分析。研究结局包括随访期间的神经功能恶化或复发性卒中。对于所有结局事件,计算相应的风险比(RR)和95%置信区间(95%CI)。
文献检索共获得4478条记录,在标题/摘要筛选阶段选出32篇进行全文阅读;11篇符合纳入标准,8项研究纳入分析(n = 1219例患者;341例有BZI)。荟萃分析表明,与无BZI组相比,BZI组结局的RR为2.10(95%CI 1.52 - 2.90)。将分析限于包括任何BZI的研究,RR为2.10(95%CI 1.38 - 3.18)。对于孤立BZI,RR为2.59(95%CI 1.24 - 5.41)。仅包括前循环卒中患者的研究中,RR为[2.96(95%CI 1.71 - 5.12)]。
本系统评价和荟萃分析表明,ICAS继发的BZI的存在可能是预测神经功能恶化和/或卒中复发的影像学生物标志物。